Jim Cramer on Gilead Sciences: “I’d Hold On to It”

Gilead Sciences, Inc. (NASDAQ:GILD) was among the stocks Jim Cramer reviewed on Mad Money while discussing the recent market rotation. During the lightning round, a caller asked for Cramer’s take on the stock, and he replied:

You know, I like what Daniel O’Day is doing. I always bump into him at the JPMorgan conference. I think he’s a smart guy, and the company’s good. I’d hold on to it. They’ve got some good franchises.

A stock market data. Photo by AlphaTradeZone on Pexels

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that develops treatments for major medical conditions like HIV, hepatitis, and COVID-19. The company also uses advanced cell therapies for cancer treatment, and it maintains several partnerships to discover new small-molecule and antibody medicines.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.